Overview: Rheumatoid Factor TestIntroduction: The Rheumatoid Factor Test detects RF to diagnose rheumatoid arthritis, causing joint pain or swelling. Following 2023 ACR guidelines, it uses immunoassays for high specificity, supporting autoimmune screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected rheumatoid arthritis.
Other Names: RF Serum Assay, Rheumatoid Arthritis Factor Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: RF testing began in the 1940s with rheumatoid arthritis research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects RF to diagnose rheumatoid arthritis, guides treatment, and evaluates patients with joint pain or swelling.
Test Parameters: 1. Rheumatoid Factor Level
Pretest Condition: No fasting required. Collect serum or plasma. Report history of joint pain, swelling, or autoimmune symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document joint pain, swelling, or family history of rheumatoid arthritis. Include current medications, especially DMARDs.
Consent: Written consent required, detailing the tests purpose, rheumatoid arthritis implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to measure RF levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for rheumatoid arthritis diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Other autoimmune diseases may cause false positives.
Clinical Significance: Positive RF confirms rheumatoid arthritis, guiding DMARD or biologic therapy. Negative results may require anti-CCP testing.
Specialist Consultation: Consult a rheumatologist for result interpretation and treatment planning.
Additional Supporting Tests: Anti-CCP antibodies, ESR, or joint imaging to confirm rheumatoid arthritis diagnosis.
Test Limitations: Non-specific for rheumatoid arthritis; clinical correlation is needed. Sample quality affects sensitivity.
References: ACR Rheumatoid Arthritis Guidelines, 2023; Arthritis & Rheumatology, Aletaha D, 2022.
